SIGLEC9 (sialic acid binding Ig like lectin 9)

2003-06-01  

Identity

HGNC
LOCATION
19q13.41
LOCUSID
ALIAS
CD329,CDw329,FOAP-9,OBBP-LIKE,siglec-9

Other Information

Locus ID:

NCBI: 27180
MIM: 605640
HGNC: 10878
Ensembl: ENSG00000129450

Variants:

dbSNP: 27180
ClinVar: 27180
TCGA: ENSG00000129450
COSMIC: SIGLEC9

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000129450ENST00000250360Q9Y336
ENSG00000129450ENST00000440804Q9Y336
ENSG00000129450ENST00000599948M0R2D4

Expression (GTEx)

0
5
10
15
20
25
30
35
40

Pathways

PathwaySourceExternal ID
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cellREACTOMER-HSA-198933
Innate Immune SystemREACTOMER-HSA-168249
Neutrophil degranulationREACTOMER-HSA-6798695

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
384127682024Expression of Siglec-9 in peripheral blood neutrophils was increased and associated with disease severity in patients with AECOPD.1
384541572024The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis.0
384127682024Expression of Siglec-9 in peripheral blood neutrophils was increased and associated with disease severity in patients with AECOPD.1
384541572024The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis.0
366889972023LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma.6
367284202023Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.4
374608712023Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response.16
378652962023The change of Siglec-9 expression in peripheral blood NK cells of SFTS patients can affect the function of NK cells.1
366889972023LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma.6
367284202023Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.4
374608712023Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response.16
378652962023The change of Siglec-9 expression in peripheral blood NK cells of SFTS patients can affect the function of NK cells.1
358542402022Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.4
358542402022Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.4
334316692021Modulation of immune cell reactivity with cis-binding Siglec agonists.25

Citation

Dessen P

SIGLEC9 (sialic acid binding Ig like lectin 9)

Atlas Genet Cytogenet Oncol Haematol. 2003-06-01

Online version: http://atlasgeneticsoncology.org/gene/42296/css/js/css/template-card.css